QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

MDXG

QT61MiMedx Group, Inc.
NASDAQ·Healthcare·Biotechnology·USA
Latest market price
3.67
+0.06+1.66%
OverviewShort InterestFilings
MDXGQT61MiMedx Group, Inc.·NASDAQ
OverviewShort InterestFilings
3.67+1.66%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E17.46EPS (ttm)
0.20
Insider Own43.85%
Shs Outstand148.95M
Perf Week-0.54%
Market Cap537.69MForward P/E46.42EPS next Y0.08Insider Trans0.28%Shs Float-Perf Month0.82%
Enterprise Value395.52MPEG-EPS next Q-0.03Inst Own-Short Float-Perf Quarter-11.99%
Income30.81MP/S1.38EPS this Y-128.75%Inst Trans-Short Ratio-Perf Half Y-49.38%
Sales389.40MP/B2.21EPS next Y237.50%ROA9.94%Short Interest-Perf YTD-45.79%
Book/sh1.63P/C7.59EPS next 5Y-ROE12.86%52W High7.99 -54.07%Perf Year-37.26%
Cash/sh1.07P/FCF8.21EPS past 3/5Y-ROIC10.81%52W Low3.03 21.12%Perf 3Y-
Dividend Est.-EV/EBITDA6.91Sales past 3/5Y16.06% 11.06%Gross Margin81.04%Volatility2.50% 2.53%Perf 5Y-
Dividend TTM-EV/Sales1.02EPS Y/Y TTM21.43%Oper. Margin10.17%ATR (14)0.14Perf 10Y-
Dividend Ex-Date-Quick Ratio4.81Sales Y/Y TTM11.75%Profit Margin7.88%RSI (14)50.75Recom2.33
Dividend Gr. 3/5Y-Current Ratio5.39EPS Q/Q-183.33%SMA200.36%Beta1.13Target Price10.00
Payout0.00%Debt/Eq0.07Sales Q/Q-32.95%SMA501.96%Rel Volume1.32Prev Close3.61
Employees837LT Debt/Eq0.07EarningsJul 29SMA200-33.04%Avg Volume1.62MPrice3.67
IPO DateFeb 12, 2008Option/ShortYes / YesEPS/Sales Surpr.28.57% -10.61%Net Debt/EBITDA-2.48Volume2,130,568Change1.66%
Analyst Ratings
DateActionAnalystRatingTarget
Feb-23-26ReiteratedUBSSell$10
Nov-15-24ReiteratedMizuho Securities$16
Jul-02-24InitiatedCantor FitzgeraldOverweight$11
Apr-29-24ReiteratedLake StreetHold$12
Sep-07-22ReiteratedH.C. Wainwright$8.00
Feb-26-18DowngradeLake StreetBuy → Hold
Feb-20-18DowngradeNeedhamStrong Buy → Hold
May-23-17DowngradeFirst AnalysisEqual Weight → Underweight
Nov-16-15UpgradeNeedhamBuy → Strong Buy
Oct-30-15UpgradeNorthland Capital MarketsMarket Perform → Outperform
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue390419349
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A747360
Gross Profit316346289
Selling, General and Administrative Excl. Other259266216
Research and Development161512
Other Operating Expense202
Operating Income396459
Interest Expense121
Unusual Expense
———
Non-Operating Income (Expense)-4-40
Net Income Before Taxes436657
Income Taxes121815
Consolidated Net Income314942
Net Income From Continuing Operations314942
Net Income314942
EPS (Recurring)0.210.330.29
EPS (Basic, Before Extraordinaries)0.210.330.29
EPS (Diluted)0.200.320.28
EBITDA578365
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio18.3521.16—
Price To Sales Ratio1.392.39—
Gross Margin81.0382.5882.81
Operating Margin10.0015.2716.91
Net Margin7.9511.6912.03
Shares Outstanding148148147
Market Capitalization5431,002—
Operating Lease Expense
———
Insider Trading Volume
$4.49$4.16$3.83$3.50$3.17● Close Price0.00K108.08K216.16K324.25K432.33KUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Maersk-Moller KimberlyChief Commercial OfficerMar 10 '26Option Exercise4.5042,845192,803357,482Mar 12 12:00 AM
Hulse William Frank IVGeneral Counsel and CAOMar 10 '26Option Exercise4.50136,364613,638624,900Mar 12 12:00 AM
DOUG RICEChief Financial OfficerMar 10 '26Option Exercise4.50243,0001,093,500508,678Mar 12 12:00 AM
Maersk-Moller KimberlyChief Commercial OfficerNov 06 '25Sale7.4258,300432,329236,982Nov 10 12:00 AM
Capper Joseph HChief Executive OfficerMay 02 '25Buy6.34200,0001,268,000529,530May 05 12:00 AM
Maersk-Moller KimberlyChief Commercial OfficerMar 17 '25Sale8.041,75914,142309,077Mar 20 12:00 AM
Hulse William Frank IVGeneral Counsel and CAOMar 13 '25Sale7.8954,596430,763440,178Mar 14 12:00 AM
Maersk-Moller KimberlyChief Commercial OfficerMar 13 '25Sale7.894,10632,396310,836Mar 14 12:00 AM
Hulse William Frank IVGeneral Counsel and CAOMar 10 '25Sale7.8081,446635,279494,774Mar 12 12:00 AM
Maersk-Moller KimberlyChief Commercial OfficerFeb 28 '25Sale8.402,11117,743265,271Mar 05 12:00 AM
Whitlow Ricci SChief Operating OfficerFeb 13 '25Sale8.2861,420508,558403,019Feb 18 12:00 AM
Hulse William Frank IVGeneral Counsel and CAOMar 13 '24Sale7.9520,381162,029479,959Mar 15 12:00 AM
Whitlow Ricci SChief Operating OfficerFeb 20 '24Sale8.0115,271122,351401,050Feb 21 12:00 AM
Whitlow Ricci SChief Operating OfficerFeb 16 '24Sale8.0715,493125,075416,321Feb 21 12:00 AM
Whitlow Ricci SChief Operating OfficerFeb 15 '24Sale8.0615,198122,496431,814Feb 16 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR